Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

BUY
$2.41 - $3.33 $17,392 - $24,032
7,217 Added 36.16%
27,177 $75,000
Q2 2019

Aug 14, 2019

BUY
$5.68 - $8.68 $14,557 - $22,246
2,563 Added 14.73%
19,960 $146,000
Q1 2019

May 14, 2019

BUY
$7.27 - $9.07 $41,082 - $51,254
5,651 Added 48.11%
17,397 $142,000
Q2 2018

Aug 14, 2018

BUY
$5.04 - $17.96 $59,199 - $210,958
11,746 New
11,746 $139,000

About Galmed Pharmaceuticals Ltd.


  • Ticker GLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,088,400
  • Market Cap $153M
  • Description
  • Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...
More about GLMD
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.